This inventor holds 1 USPTO granted patent. Top assignee: Laboratoires Serono S.a.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Maureen Ajuebor: Innovator in Hepatitis Treatment
Introduction
Maureen Ajuebor is a notable inventor based in Calgary, Canada. She has made significant contributions to the field of medical research, particularly in the treatment of liver diseases. Her innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Maureen Ajuebor holds a patent for "Methods of reducing serum alanine transferase levels in a subject with hepatitis." This patent focuses on CC-Chemokine mutants that possess reduced Glycosaminoglycans (GAG)-binding properties, which are effective against liver fibrotic inflammatory and/or autoimmune diseases. The mutants of CCL5/RANTES with reduced GAG-binding properties are particularly preferred in her research.
Career Highlights
Ajuebor's career is marked by her dedication to advancing medical science. She has worked with Laboratoires Serono S.A., where she has collaborated with other talented professionals in the field. Her work has been instrumental in developing new therapeutic approaches for liver-related conditions.
Collaborations
Throughout her career, Maureen has collaborated with notable colleagues, including Amanda Proudfoot and Mark Swain. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Maureen Ajuebor's contributions to medical research, particularly in hepatitis treatment, highlight her role as an influential inventor. Her patented methods and collaborations reflect her commitment to improving health outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile